Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Correlation of Serum Vitamin D Level with the Development of Endocrine Autoimmune Complications During Treatment with Immune Checkpoint Inhibitors
Sponsor: Icahn School of Medicine at Mount Sinai
Listed as NCT04615988, this observational or N/A phase trial focuses on Cancer and PD-1 and remains actively recruiting participants. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Dec 2024 — Present [monthly]
Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Nov 2022 — Dec 2023 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Sep 2021 — Nov 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Not Yet Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .